|
![]() |
|||
|
||||
OverviewPhenotypic drug discovery has been highlighted in the past decade as an important strategy in the discovery of new medical entities. How many marketed drugs are derived from phenotypic screens? From the most recent examples, what were the factors enabling target identification and validation? This book answers these questions by elaborating on fundamental capabilities required for phenotypic drug discovery and using case studies to illustrate approaches and key success factors. Written and edited by experienced practitioners from both industry and academia, this publication will equip researchers with a thought-provoking guide to the application and future development of contemporary phenotypic drug discovery for clinical success. Full Product DetailsAuthor: Beverley Isherwood (AstraZeneca, UK) , Angelique Augustin (Hoffmann-La Roche, Switzerland) , Rick Davies , Beverley IsherwoodPublisher: Royal Society of Chemistry Imprint: Royal Society of Chemistry Volume: Volume 77 Weight: 0.520kg ISBN: 9781788018760ISBN 10: 1788018761 Pages: 271 Publication Date: 10 December 2020 Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |